Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA(2)DS(2)-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F19%3A43918247" target="_blank" >RIV/00216208:11120/19:43918247 - isvavai.cz</a>
Result on the web
<a href="https://doi.org/10.1093/ehjcvp/pvz016" target="_blank" >https://doi.org/10.1093/ehjcvp/pvz016</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1093/ehjcvp/pvz016" target="_blank" >10.1093/ehjcvp/pvz016</a>
Alternative languages
Result language
angličtina
Original language name
Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA(2)DS(2)-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke
Original language description
Oral anticoagulation in patients presenting with non-valvular atrial fibrillation and a CHA(2)DS(2)-VASc score of 1 (CHA(2)DS(2)-VASc of 2 in women) remains a challenging approach in clinical practice. Therapeutic decisions need to balance the individual benefit of reducing thromboembolic risk against the potential harm due to an increase in bleeding risk in this intermediate risk patient population. Within the current opinion statement of the European Society of Cardiology working group of cardiovascular pharmacotherapy and the European Society of Cardiology council on stroke the currently available evidence on the anti-thrombotic management in patients presenting with a CHA(2)DS(2)-VASc of 1 is summarized. Easily applicable tools for a personalized refinement of the individual thromboembolic risk in patients with atrial fibrillation and a CHA(2)DS(2)-VASc score of 1 that guide clinicians through the question whether to anticoagulate or not are provided.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30201 - Cardiac and Cardiovascular systems
Result continuities
Project
—
Continuities
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Others
Publication year
2019
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
European Heart Journal: Cardiovascular Pharmacotherapy
ISSN
2055-6837
e-ISSN
—
Volume of the periodical
5
Issue of the periodical within the volume
3
Country of publishing house
GB - UNITED KINGDOM
Number of pages
10
Pages from-to
171-180
UT code for WoS article
000484382600008
EID of the result in the Scopus database
2-s2.0-85068427343